Evidence map›Paper›PMID 30100262›Full record

ArticleDevelopmental cell2018

Trisomy 21 Represses Cilia Formation and Function.

Domenico F Galati, Kelly D Sullivan, Andrew T Pham, Joaquin M Espinosa, Chad G Pearson

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. The Role of Oxidative Stress in Trisomy 21 Phenotype.Cellular and molecular neurobiology · 2023
    Review
  18. Article
  19. The E3 ligase Poe promotes Pericentrin degradation.Molecular biology of the cell · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Domenico F GalatiDepartment of Cell and Developmental Biology, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: nick.galati@wwu.edu.
Kelly D SullivanDepartment of Pharmacology, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA.
Andrew T PhamDepartment of Cell and Developmental Biology, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA.
Joaquin M EspinosaDepartment of Pharmacology, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA.
Chad G PearsonDepartment of Cell and Developmental Biology, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA; Linda Crnic Institute for Down Syndrome, University of Colorado-Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: chad.pearson@ucdenver.edu.
University of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Stress- and Promoter-Specific Mechanisms of Transcritpional Activation by p53R01CA117907 · NCI · UNIVERSITY OF COLORADO DENVER · PI ESPINOSA, JOAQUIN M. · 2006 to 2022
$4.4M
Mechanisms of centriole assembly and stabilityR01GM099820 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI PEARSON, CHAD G · 2012 to 2020
$2.9M
Mechanisms of gene expression control during the cellular response to hypoxiaR01GM120109 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI ESPINOSA, JOAQUIN M. · 2016 to 2019
$1.2M
Basal body-mediated regulation of ciliary Ca2+ during cilia length controlF32GM117934 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI GALATI, DOMENICO FORTUNATO · 2016 to 2017
$116k
NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA117907NIGMS NIH HHS F32 GM117934NIGMS NIH HHS R01 GM099820NIGMS NIH HHS R01 GM120109
6 · The paper itself

Abstract

Trisomy 21 (T21) is the most prevalent human chromosomal disorder, causing a range of cardiovascular, musculoskeletal, and neurological abnormalities. However, the cellular processes disrupted by T21 are poorly understood. Consistent with the clinical overlap between T21 and ciliopathies, we discovered that T21 disrupts cilia formation and signaling. Cilia defects arise from increased expression of Pericentrin, a centrosome scaffold and trafficking protein encoded on chromosome 21. Elevated Pericentrin is necessary and sufficient for T21 cilia defects. Pericentrin accumulates at centrosomes and dramatically in the cytoplasm surrounding centrosomes. Centrosome Pericentrin recruits more γ-tubulin and enhances microtubules, whereas cytoplasmic Pericentrin assembles into large foci that do not efficiently traffic. Moreover, the Pericentrin-associated cilia assembly factor IFT20 and the ciliary signaling molecule Smoothened do not efficiently traffic to centrosomes and cilia. Thus, increased centrosome protein dosage produces ciliopathy-like outcomes in T21 cells by decreasing trafficking between the cytoplasm, centrosomes, and cilia.

Indexed as

AnimalsAntigensCarrier ProteinsCell MovementCells, CulturedCentrosomeCiliaDown SyndromeFemaleHedgehog ProteinsHumansMaleMiceAntigensCarrier ProteinsHedgehog ProteinsIFT20 protein, humanpericentrincentrosomeciliaDown syndromePericentrinSonic hedgehogtraffickingTrisomy 21

Identifiers

PMID30100262
PMCPMC6557141
OpenAlexW2886116436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.